Research Article
Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects
Table 1
Clinical, biochemical, and hormonal features according to the vitamin D status in young CHD patients.
| | Markers | Serum 25OHD levels | | | <10.0 ng/mL | 10.0–19.9 ng/mL | 20.0–30.0 ng/mL | >30.0 ng/mL |
| | 33 | 88 | 48 | 61 | | | Age (years) | 8.3
(5.6–11.2) | 5.8
(3.8–9.0) | 7.1
(4.6–9.4) | 5.7
(2.8–8.7) | 0.02 | | Male/female | 12/21 | 43/45 | 23/25 | 35/26 | ns | | HSDS | 0.02
(−0.54–0.65) | −0.25
(−1.09–0.77) | −0.06
(−1.4–0.31) | −0.83
(−1.6–0.11) | 0.002 | | (%) | 101.5
(91.5–112.5) | 97.0
(93.0–107.0) | 102.0
(94.0–114.5) | 95.0
(88.0–104.5) | 0.03 | Creatinine
(mg/dL) | 0.46
(0.37–0.57) | 0.41
(0.36–0.51) | 0.45
(0.38–0.51) | 0.40
(0.32–0.45) | 0.01 | Alb/calcium
(mg/dL) | 9.07
(8.80–9.40) | 8.97
(8.79–9.25) | 9.04
(8.72–9.31) | 9.02
(8.80–9.36) | ns | | Ionized Ca (mmol/L) | 1.19
(1.07–1.25) | 1.19
(1.13–1.26) | 1.22
(1.08–1.30) | 1.21
(1.13–1.30) | ns | Magnesium
(mg/dL) | 2.08
(1.98–2.14) | 2.07
(1.95–2.19) | 2.15
(1.98–2.23) | 2.05
(1.97–2.15) | ns | Phosphate
(mg/dL) | 4.86
(4.37–5.38) | 5.18
(4.75–5.67) | 5.28
(4.77–5.65) | 5.11
(4.69–5.67) | ns | PTH
(pg/mL) | 34.0
(21.5–52.5) | 31.0
(24.2–48.7) | 31.5
(23.2–43.5) | 27.0
(17.5–38.0) | 0.003 | NT-proBNP
(ng/mL) | 104.6
(63.2–179.7) | 89.1
(43.7–149.2) | 129.7
(57.5–283.3) | 128.3
(62.9–193.6) | ns |
|
|
versus 25OHD < 10 ng/dL; versus 25OHD 20–30 ng/dL; ns, not significant; Alb/calcium, albumin-corrected calcium; , weight/height; HSDS, height standard deviation score; ionized Ca, ionized calcium.
|
